Market Overview:
The global oxycodone hydrochloride market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for abuse-deterrent formulations (ADFs) of oxycodone hydrochloride. Based on type, the global oxycodone hydrochloride market is segmented into oxycodone hydrochloride and type II. The oxycodone hydrochloride segment is further sub-segmented into tablet, oral solution, oral capsule, and intravenous fluid. The tablet segment is expected to account for the largest share of the global oxycodone hydrochloride market in 2018 owing to its high usage rates across various applications such as pain management and cancer treatment.
Product Definition:
Oxycodone Hydrochloride is a prescription opioid pain medication. It is used to treat moderate to severe pain.
Oxycodone Hydrochloride:
Oxycodone Hydrochloride, also known as OxyContin, is an opioid pain medication developed by the Purdue Pharma L.P. It was first approved by the U.S.
Type II:
Type II is also known as Opioid-induced Constipation (OIC) or opioid-induced diarrhea. It is a class of drug that affects the way the brain and body respond to pain. The most commonly abused opioids are oxycodone, hydrocodone, codeine, morphine, and fentanyl.
Application Insights:
Oral solution was the most dominant application segment in terms of revenue share in 2017. This is due to high usage rates and increasing awareness regarding drug abuse. In addition, growing use of oral solution for the treatment of pain caused by cancer and arthritis is expected to boost market growth during the forecast period.
The tablet accounted for a significant share owing to its wide usage as a single-agent or in combination with other drugs for treating chronic pain conditions such as neurogenic, arthritic, cancer and headache. Moreover, rising incidences associated with OxyContin Tablets (oxycodone hydrochloride) abuse are anticipated to drive demand over the forecast period thereby supporting market growth during this period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from chronic pain and high level of awareness regarding its treatment. In addition, availability of highly effective OxyContin-based products is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to growing population, especially in China and India. Increasing prevalence of chronic diseases such as diabetes and arthritis among others are expected fuel demand for opioid-containing products in these countries which will further boost market growth.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This will lead to an increase in the demand for oxycodone hydrochloride as it is prescribed for pain relief in elderly patients.
- Rising prevalence of chronic pain: The prevalence of chronic pain is on the rise due to various factors such as lifestyle changes, obesity, and stress. This will lead to an increase in the demand for oxycodone hydrochloride as a treatment option for chronic pain relief.
- Growing awareness about opioids: There is growing awareness about the benefits and risks associated with opioids among healthcare professionals and consumers alike. This will lead to an increase in the use of oxycodone hydrochloride for various indications such as cancer-related pain, postoperative analgesia, etc., thereby driving its market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxycodone Hydrochloride Market Research Report
By Type
Oxycodone Hydrochloride, Type II
By Application
Tablet, Oral Solution, Oral Capsule, Intravenous Fluid
By Companies
Mallinckrodt, Purdue Pharma, Noramco(Johnson & Johnson), Siegfried, Cepia-Sanofi, Macfarlan Smith, Chattem Chemicals(Sun Pharma), Temad
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oxycodone Hydrochloride Market Report Segments:
The global Oxycodone Hydrochloride market is segmented on the basis of:
Types
Oxycodone Hydrochloride, Type II
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Oral Solution, Oral Capsule, Intravenous Fluid
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt
- Purdue Pharma
- Noramco(Johnson & Johnson)
- Siegfried
- Cepia-Sanofi
- Macfarlan Smith
- Chattem Chemicals(Sun Pharma)
- Temad
Highlights of The Oxycodone Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxycodone Hydrochloride
- Type II
- By Application:
- Tablet
- Oral Solution
- Oral Capsule
- Intravenous Fluid
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxycodone Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxycodone hydrochloride is a narcotic pain reliever medication. It is used to relieve moderate to severe pain.
Some of the key players operating in the oxycodone hydrochloride market are Mallinckrodt, Purdue Pharma, Noramco(Johnson & Johnson), Siegfried, Cepia-Sanofi, Macfarlan Smith, Chattem Chemicals(Sun Pharma), Temad.
The oxycodone hydrochloride market is expected to register a CAGR of 3.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxycodone Hydrochloride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxycodone Hydrochloride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxycodone Hydrochloride Market - Supply Chain
4.5. Global Oxycodone Hydrochloride Market Forecast
4.5.1. Oxycodone Hydrochloride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxycodone Hydrochloride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxycodone Hydrochloride Market Absolute $ Opportunity
5. Global Oxycodone Hydrochloride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxycodone Hydrochloride Market Size and Volume Forecast by Type
5.3.1. Oxycodone HydrochlorideII
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxycodone Hydrochloride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxycodone Hydrochloride Market Size and Volume Forecast by Application
6.3.1. Tablet
6.3.2. Oral Solution
6.3.3. Oral Capsule
6.3.4. Intravenous Fluid
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxycodone Hydrochloride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxycodone Hydrochloride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxycodone Hydrochloride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxycodone Hydrochloride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxycodone Hydrochloride Demand Share Forecast, 2019-2026
9. North America Oxycodone Hydrochloride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxycodone Hydrochloride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxycodone Hydrochloride Market Size and Volume Forecast by Application
9.4.1. Tablet
9.4.2. Oral Solution
9.4.3. Oral Capsule
9.4.4. Intravenous Fluid
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxycodone Hydrochloride Market Size and Volume Forecast by Type
9.7.1. Oxycodone HydrochlorideII
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxycodone Hydrochloride Demand Share Forecast, 2019-2026
10. Latin America Oxycodone Hydrochloride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxycodone Hydrochloride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxycodone Hydrochloride Market Size and Volume Forecast by Application
10.4.1. Tablet
10.4.2. Oral Solution
10.4.3. Oral Capsule
10.4.4. Intravenous Fluid
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxycodone Hydrochloride Market Size and Volume Forecast by Type
10.7.1. Oxycodone HydrochlorideII
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxycodone Hydrochloride Demand Share Forecast, 2019-2026
11. Europe Oxycodone Hydrochloride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxycodone Hydrochloride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxycodone Hydrochloride Market Size and Volume Forecast by Application
11.4.1. Tablet
11.4.2. Oral Solution
11.4.3. Oral Capsule
11.4.4. Intravenous Fluid
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxycodone Hydrochloride Market Size and Volume Forecast by Type
11.7.1. Oxycodone HydrochlorideII
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projecions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxycodone Hydrochloride Demand Share, 2019-2026
12. Asia Pacific Oxycodone Hydrochloride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxycodone Hydrochloride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxycodone Hydrochloride Market Size and Volume Forecast by Application
12.4.1. Tablet
12.4.2. Oral Solution
12.4.3. Oral Capsule
12.4.4. Intravenous Fluid
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxycodone Hydrochloride Market Size and Volume Forecast by Type
12.7.1. Oxycodone HydrochlorideII
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxycodone Hydrochloride Demand Share, 2019-2026
13. Middle East & Africa Oxycodone Hydrochloride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxycodone Hydrochloride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxycodone Hydrochloride Market Size and Volume Forecast by Application
13.4.1. Tablet
13.4.2. Oral Solution
13.4.3. Oral Capsule
13.4.4. Intravenous Fluid
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxycodone Hydrochloride Market Size and Volume Forecast by Type
13.7.1. Oxycodone HydrochlorideII
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxycodone Hydrochloride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxycodone Hydrochloride Market: Market Share Analysis
14.2. Oxycodone Hydrochloride Distributors and Customers
14.3. Oxycodone Hydrochloride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mallinckrodt
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Purdue Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Noramco(Johnson & Johnson)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siegfried
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cepia-Sanofi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Macfarlan Smith
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Chattem Chemicals(Sun Pharma)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Temad
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
